Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials. Zhang W, Dai T, Wang D, Zhu Y, et al. BMC Cancer 2024;24:1522.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Dai T, Wang D, Zhu Y, et al. Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials. BMC Cancer 2024;24:1522.
PMID: 39696048